|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000205808 |
Summary for PPAPDC2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000205808 | Gene symbol | PPAPDC2 |
| Gene name | phospholipid phosphatase 6 | |
| HGNC | 23682 | |
| Entrez ID | 403313 | |
| Gene type | protein_coding | |
| Synonyms | PLPP6|FLJ90191|FLJ46512|PDP1 | |
| UniProtAcc | Q8IY26 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PPAPDC2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PPAPDC2 | 9.80e+02 | -1.01e+00 | 3.10e-01 | -3.26e+00 | 1.11e-03 | 3.71e-03 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for PPAPDC2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PPAPDC2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg13763482 | chr9:4663107 | CGI:chr9:4662252-4662951 | promoter,exon,CDS,gene body | 3.81e-01 | 2.56e-01 | 3.03e+00 | 2.43e-03 | 1.50e-02 | 1.26e-01 |
| ACC | cg13763482 | chr9:4663107 | CGI:chr9:4662252-4662951 | promoter,exon,CDS,gene body | 5.76e-01 | 7.25e-01 | -3.54e+00 | 3.94e-04 | 2.36e-03 | -1.49e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg13696752 | chr9:4662858 | CGI:chr9:4662252-4662951 | promoter,exon,CDS,gene body | 2.17e-01 | 3.20e-01 | -3.81e+00 | 1.41e-04 | 8.14e-04 | -1.03e-01 |
| LUSC | cg13763482 | chr9:4663107 | CGI:chr9:4662252-4662951 | promoter,exon,CDS,gene body | 4.14e-01 | 5.48e-01 | -3.62e+00 | 2.92e-04 | 1.20e-03 | -1.34e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg27204993 | chr9:4662937 | CGI:chr9:4662252-4662951 | promoter,exon,CDS,gene body | 2.46e-01 | 3.57e-01 | -3.49e+00 | 4.86e-04 | 3.60e-03 | -1.10e-01 |
Top |
Exon skipping events with PSI in TCGA for PPAPDC2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PPAPDC2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PPAPDC2 |
| TFs related to PPAPDC2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | ZNF235 | PPAPDC2 | 4.51e+00 | 9.84e-01 | 3.63e+00 | 9.04e-03 | Male-biased |
| DLBC | ZNF287 | PPAPDC2 | 4.41e+00 | 9.83e-01 | 3.53e+00 | 9.03e-03 | Male-biased |
| LAML | FOXJ2 | PPAPDC2 | 4.60e+00 | 9.84e-01 | 3.64e+00 | 8.51e-03 | Male-biased |
| LAML | MIXL1 | PPAPDC2 | 6.31e+00 | 9.85e-01 | 5.49e+00 | 1.46e-02 | Male-biased |
| LAML | NANOG | PPAPDC2 | 4.80e+00 | 9.88e-01 | 3.77e+00 | 6.44e-03 | Male-biased |
| LAML | PHOX2A | PPAPDC2 | 5.91e+00 | 9.92e-01 | 4.88e+00 | 6.82e-03 | Male-biased |
| LAML | PROP1 | PPAPDC2 | 6.16e+00 | 9.88e-01 | 5.27e+00 | 1.10e-02 | Male-biased |
| LAML | PRRX1 | PPAPDC2 | 5.80e+00 | 9.90e-01 | 4.83e+00 | 8.39e-03 | Male-biased |
| LAML | UNCX | PPAPDC2 | 5.76e+00 | 9.92e-01 | 4.73e+00 | 6.51e-03 | Male-biased |
| LAML | ZNF584 | PPAPDC2 | 5.02e+00 | 9.87e-01 | 4.08e+00 | 9.04e-03 | Male-biased |
| MESO | FOXJ2 | PPAPDC2 | 4.37e+00 | 9.90e-01 | 2.72e+00 | 2.19e-03 | Male-biased |
| MESO | NANOG | PPAPDC2 | 4.68e+00 | 9.91e-01 | 3.19e+00 | 3.94e-03 | Male-biased |
| MESO | PHOX2A | PPAPDC2 | 5.65e+00 | 9.86e-01 | 4.51e+00 | 1.30e-02 | Male-biased |
| MESO | PROP1 | PPAPDC2 | 5.91e+00 | 9.81e-01 | 4.88e+00 | 1.79e-02 | Male-biased |
| MESO | PRRX1 | PPAPDC2 | 5.54e+00 | 9.85e-01 | 4.43e+00 | 1.37e-02 | Male-biased |
| MESO | UNCX | PPAPDC2 | 5.45e+00 | 9.88e-01 | 4.25e+00 | 1.03e-02 | Male-biased |
| MESO | ZNF45 | PPAPDC2 | 4.77e+00 | 9.88e-01 | 3.47e+00 | 7.54e-03 | Male-biased |
| MESO | ZNF584 | PPAPDC2 | 4.94e+00 | 9.93e-01 | 3.39e+00 | 3.28e-03 | Male-biased |
| PCPG | ZNF770 | PPAPDC2 | 4.12e+00 | 9.81e-01 | 3.20e+00 | 5.70e-03 | Male-biased |
| PPAPDC2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PPAPDC2 |
| RBPs related to ES in PPAPDC2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PPAPDC2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs6476722 | chr9:3866849:G:A | - | -0.135573104415027 | 0.000124776468845567 | HNSC | Female-baised eQTL |
| rs7043559 | chr9:7940329:C:G | - | 0.617632530800183 | 0.00305685788860177 | GBM | Female-baised eQTL |
| rs72700585 | chr9:14443257:C:T | - | 0.100467162804576 | 0.0155138638664538 | SARC | Female-baised eQTL |
| rs62534709 | chr9:9728370:C:T | - | 0.0822396316634323 | 0.0442446145134328 | SARC | Female-baised eQTL |
| rs77082293 | chr9:7799393:G:T | - | 0.125284326937931 | 0.000620810446110737 | STAD | Female-baised eQTL |
| rs10976595 | chr9:7812920:T:C | - | 0.100980169016701 | 0.00631002673006852 | STAD | Female-baised eQTL |
| rs10976593 | chr9:7811060:T:G | - | 0.103257881895701 | 0.00664368581426421 | STAD | Female-baised eQTL |
| rs72697262 | chr9:7811335:C:T | - | 0.102867226372696 | 0.00690161066365583 | STAD | Female-baised eQTL |
| rs72697263 | chr9:7811508:A:G | - | 0.102933296675225 | 0.00700339883566516 | STAD | Female-baised eQTL |
| rs72697264 | chr9:7811692:T:A | - | 0.102933296675225 | 0.00700339883566516 | STAD | Female-baised eQTL |
| rs7470720 | chr9:7814420:A:T | - | 0.10237398139335 | 0.00747060058180671 | STAD | Female-baised eQTL |
| rs12238126 | chr9:7815162:A:G | - | 0.10237398139335 | 0.00747060058180671 | STAD | Female-baised eQTL |
| rs141602962 | chr9:7815826:A:G | - | 0.10237398139335 | 0.00747060058180671 | STAD | Female-baised eQTL |
| rs72697275 | chr9:7816012:A:G | - | 0.10237398139335 | 0.00747060058180671 | STAD | Female-baised eQTL |
| rs72697276 | chr9:7816013:C:G | - | 0.10237398139335 | 0.00747060058180671 | STAD | Female-baised eQTL |
| rs10976598 | chr9:7816710:A:G | - | 0.10237398139335 | 0.00747060058180671 | STAD | Female-baised eQTL |
| rs77763173 | chr9:7116128:C:T | - | 0.0832536339451597 | 0.0208989738824764 | STAD | Female-baised eQTL |
| rs4741013 | chr9:1032153:C:T | - | 0.0794176307007207 | 0.0391144923051217 | STAD | Female-baised eQTL |
| rs16928234 | chr9:8645448:A:C | - | 0.0639277959646249 | 0.0132916926502706 | LUAD | Female-baised eQTL |
| rs16928002 | chr9:8484039:C:T | - | 0.0623110218037727 | 0.018936055650801 | LUAD | Female-baised eQTL |
| rs10124043 | chr9:5902569:C:A | - | -0.044613480641851 | 0.0230232889413205 | LUAD | Female-baised eQTL |
| rs1331380 | chr9:5900426:T:C | - | -0.0426365721956425 | 0.0294923859627524 | LUAD | Female-baised eQTL |
| rs7036876 | chr9:13016760:G:A | - | 0.0938125401697428 | 0.0303005451540339 | LUAD | Female-baised eQTL |
| rs10738314 | chr9:13019204:C:T | - | -0.0938125401697427 | 0.0303005451540339 | LUAD | Female-baised eQTL |
| rs72700311 | chr9:8646918:C:T | - | 0.0569795209463567 | 0.0318270345124932 | LUAD | Female-baised eQTL |
| rs72698264 | chr9:8637993:C:T | - | 0.0555599448453432 | 0.0423300616663889 | LUAD | Female-baised eQTL |
| rs11795341 | chr9:8643773:A:G | - | 0.0551971075940915 | 0.0437000333403167 | LUAD | Female-baised eQTL |
| rs72698292 | chr9:8643403:T:A | - | 0.0550683862919181 | 0.0444529950500651 | LUAD | Female-baised eQTL |
| rs72698295 | chr9:8644911:A:C | - | 0.0550683862919181 | 0.0444529950500651 | LUAD | Female-baised eQTL |
| rs11793328 | chr9:8643764:C:A | - | 0.0548409188321707 | 0.0466741883279603 | LUAD | Female-baised eQTL |
| rs1556526 | chr9:9414923:G:C | - | -0.0543767860621145 | 0.0487971791159277 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2586374 | chr9:11623397:A:G | - | 0.254311046203092 | 0.00784471839823615 | SARC | Male-baised eQTL |
| rs2185464 | chr9:6924843:C:T | - | -0.117108856999598 | 0.0172661088725146 | SARC | Male-baised eQTL |
| rs2185463 | chr9:6924416:A:G | - | -0.110953091795092 | 0.0344280719083172 | SARC | Male-baised eQTL |
| rs7859425 | chr9:11668835:T:G | - | 0.272917017277045 | 0.0349321300869348 | SARC | Male-baised eQTL |
| rs7043262 | chr9:6926738:G:A | - | -0.110191358351386 | 0.0371830239692317 | SARC | Male-baised eQTL |
| rs12380111 | chr9:6924118:T:C | - | -0.110180258348544 | 0.037229957284398 | SARC | Male-baised eQTL |
| rs77220124 | chr9:12173106:G:A | - | 0.0885516911702529 | 0.026819835047577 | STAD | Male-baised eQTL |
| rs3780394 | chr9:5464376:A:C | - | 0.085705549914821 | 0.0431274342414536 | STAD | Male-baised eQTL |
| rs3858032 | chr9:2826674:C:T | - | 0.0457840281774421 | 0.0286836615776961 | KIRC | Male-baised eQTL |
| rs7848270 | chr9:1170227:G:A | - | -0.0351089865666371 | 0.0254021193939705 | BLCA | Male-baised eQTL |
| rs7864742 | chr9:1164570:T:C | - | -0.032723258374533 | 0.0461037871066862 | BLCA | Male-baised eQTL |
| rs4741128 | chr9:11222575:A:C | - | 0.0647410203870689 | 0.000529876019342222 | LUAD | Male-baised eQTL |
| rs10809391 | chr9:11221398:G:A | - | 0.0655400939864462 | 0.000543819649345482 | LUAD | Male-baised eQTL |
| rs10959635 | chr9:11221924:G:C | - | 0.0655400939864462 | 0.000543819649345482 | LUAD | Male-baised eQTL |
| rs10959636 | chr9:11222107:G:A | - | 0.0655400939864462 | 0.000543819649345482 | LUAD | Male-baised eQTL |
| rs10959639 | chr9:11222988:A:G | - | 0.0655400939864462 | 0.000543819649345482 | LUAD | Male-baised eQTL |
| rs2104967 | chr9:11236085:C:T | - | 0.063482906520985 | 0.000622572551757786 | LUAD | Male-baised eQTL |
| rs2095301 | chr9:11236252:C:T | - | 0.063482906520985 | 0.000622572551757786 | LUAD | Male-baised eQTL |
| rs10959656 | chr9:11243225:T:A | - | 0.0633031762493908 | 0.000656394587887167 | LUAD | Male-baised eQTL |
| rs10081627 | chr9:11226435:T:C | - | 0.0634119696115694 | 0.00074953233926482 | LUAD | Male-baised eQTL |
| rs16927194 | chr9:11226954:T:C | - | 0.0634119696115694 | 0.00074953233926482 | LUAD | Male-baised eQTL |
| rs12339804 | chr9:11231292:A:C | - | 0.063812390516826 | 0.000758622203400922 | LUAD | Male-baised eQTL |
| rs10959659 | chr9:11247858:A:C | - | 0.0617427881922718 | 0.0010305361319717 | LUAD | Male-baised eQTL |
| rs9406419 | chr9:11248863:T:C | - | 0.0617427881922718 | 0.0010305361319717 | LUAD | Male-baised eQTL |
| rs4741132 | chr9:11249689:G:T | - | 0.0617427881922718 | 0.0010305361319717 | LUAD | Male-baised eQTL |
| rs4358849 | chr9:1337359:C:T | - | 0.0879450855361025 | 0.00122159126153561 | LUAD | Male-baised eQTL |
| rs4740484 | chr9:11242677:C:T | - | 0.0605711649382647 | 0.0013931590480963 | LUAD | Male-baised eQTL |
| rs4741130 | chr9:11242811:C:T | - | 0.0605711649382647 | 0.0013931590480963 | LUAD | Male-baised eQTL |
| rs10959649 | chr9:11238820:T:C | - | 0.060545468396611 | 0.00146862096351344 | LUAD | Male-baised eQTL |
| rs10959665 | chr9:11250977:T:C | - | 0.0619941447992118 | 0.0017629851455258 | LUAD | Male-baised eQTL |
| rs11543876 | chr9:11251045:G:C | - | 0.0619941447992118 | 0.0017629851455258 | LUAD | Male-baised eQTL |
| rs10809361 | chr9:11149141:T:C | - | 0.0597284138627361 | 0.00208271197413364 | LUAD | Male-baised eQTL |
| rs116226805 | chr9:11245327:T:C | - | 0.0591090037580319 | 0.0020827907182259 | LUAD | Male-baised eQTL |
| rs10809404 | chr9:11250135:A:T | - | 0.0591090037580319 | 0.0020827907182259 | LUAD | Male-baised eQTL |
| rs10491777 | chr9:14352002:C:T | - | 0.073969009507902 | 0.00260498617714757 | LUAD | Male-baised eQTL |
| rs16927838 | chr9:1342663:C:T | - | 0.0833710191337319 | 0.0026712649123289 | LUAD | Male-baised eQTL |
| rs10959570 | chr9:11148563:G:A | - | 0.0568084325067249 | 0.00283663637680223 | LUAD | Male-baised eQTL |
| rs10809360 | chr9:11146606:G:T | - | 0.0576355468564334 | 0.00324037231360649 | LUAD | Male-baised eQTL |
| rs10959663 | chr9:11250650:A:T | - | 0.0587793717086127 | 0.00345465491107875 | LUAD | Male-baised eQTL |
| rs55852226 | chr9:14356939:T:C | - | 0.0633534131170549 | 0.00445484994225445 | LUAD | Male-baised eQTL |
| rs10809402 | chr9:11247762:A:T | - | 0.056027217939243 | 0.0047434747479088 | LUAD | Male-baised eQTL |
| rs10959660 | chr9:11247905:T:C | - | 0.056027217939243 | 0.0047434747479088 | LUAD | Male-baised eQTL |
| rs11526320 | chr9:11249076:T:A | - | 0.056027217939243 | 0.0047434747479088 | LUAD | Male-baised eQTL |
| rs10959662 | chr9:11249522:C:T | - | 0.056027217939243 | 0.0047434747479088 | LUAD | Male-baised eQTL |
| rs4741133 | chr9:11249721:C:T | - | 0.056027217939243 | 0.0047434747479088 | LUAD | Male-baised eQTL |
| rs10809400 | chr9:11247205:G:A | - | 0.0560286071693928 | 0.00483620925929795 | LUAD | Male-baised eQTL |
| rs12379369 | chr9:14359001:C:T | - | 0.061873926381998 | 0.00569860613168171 | LUAD | Male-baised eQTL |
| rs10959664 | chr9:11250820:G:T | - | 0.0560706953463059 | 0.00737001222201143 | LUAD | Male-baised eQTL |
| rs10491909 | chr9:9962498:A:G | - | 0.055829031026326 | 0.0137538613618693 | LUAD | Male-baised eQTL |
| rs10119093 | chr9:11246297:C:T | - | 0.0505158416403675 | 0.0144961389441955 | LUAD | Male-baised eQTL |
| rs2382270 | chr9:11139558:T:C | - | 0.0533288973198089 | 0.017727429218416 | LUAD | Male-baised eQTL |
| rs12235469 | chr9:11141679:G:A | - | 0.0533288973198089 | 0.017727429218416 | LUAD | Male-baised eQTL |
| rs12237345 | chr9:11141725:A:G | - | 0.0533288973198089 | 0.017727429218416 | LUAD | Male-baised eQTL |
| rs10283787 | chr9:4634211:A:G | - | 0.0485324132229015 | 0.0217827839325259 | LUAD | Male-baised eQTL |
| rs3852394 | chr9:4634401:C:T | - | 0.0485324132229015 | 0.0217827839325259 | LUAD | Male-baised eQTL |
| rs10959563 | chr9:11141099:G:A | - | 0.0500866751453157 | 0.0233601207631495 | LUAD | Male-baised eQTL |
| rs4740795 | chr9:4636095:G:A | - | 0.0480350424170143 | 0.0245377388017103 | LUAD | Male-baised eQTL |
| rs75886015 | chr9:1607991:G:A | - | 0.0624618231049729 | 0.0247499914121802 | LUAD | Male-baised eQTL |
| rs2273900 | chr9:4635525:A:G | - | 0.0477506969780258 | 0.0263077466331256 | LUAD | Male-baised eQTL |
| rs79999108 | chr9:1605264:C:T | - | 0.0628473701787052 | 0.0263189727456455 | LUAD | Male-baised eQTL |
| rs6474637 | chr9:11170997:A:T | - | 0.0471999013460713 | 0.0265073182172444 | LUAD | Male-baised eQTL |
| rs7860014 | chr9:9962204:C:T | - | 0.0527310841049873 | 0.0275347242764691 | LUAD | Male-baised eQTL |
| rs66869531 | chr9:905218:G:C | - | 0.0690636446188233 | 0.0308924381006599 | LUAD | Male-baised eQTL |
| rs10974390 | chr9:4203214:A:G | - | 0.0558705634036943 | 0.0327140512737255 | LUAD | Male-baised eQTL |
| rs113422864 | chr9:305392:G:C | - | 0.0663647810694139 | 0.0337018641738736 | LUAD | Male-baised eQTL |
| rs12004018 | chr9:1564508:C:A | - | 0.0568065911254907 | 0.0344402364931754 | LUAD | Male-baised eQTL |
| rs4742028 | chr9:4631845:T:C | - | 0.0454307959911942 | 0.0349889087100517 | LUAD | Male-baised eQTL |
| rs10815041 | chr9:4633229:A:G | - | 0.0454307959911942 | 0.0349889087100517 | LUAD | Male-baised eQTL |
| rs13298047 | chr9:1564261:A:C | - | 0.05547948834843 | 0.0360600711107361 | LUAD | Male-baised eQTL |
| rs7019848 | chr9:11243611:G:C | - | 0.0357593627083885 | 0.0375590637781161 | LUAD | Male-baised eQTL |
| rs9721644 | chr9:11242189:C:T | - | 0.0357092642662032 | 0.038744413970618 | LUAD | Male-baised eQTL |
| rs10815046 | chr9:4641755:C:T | - | 0.0449954373631435 | 0.0387473238073208 | LUAD | Male-baised eQTL |
| rs4742035 | chr9:4640212:C:T | - | 0.0431838006398304 | 0.0395339416753705 | LUAD | Male-baised eQTL |
| rs4741333 | chr9:13784092:G:A | - | 0.0391910813302002 | 0.0409033898911192 | LUAD | Male-baised eQTL |
| rs12685677 | chr9:2498746:G:A | - | 0.0395157343266829 | 0.0445027226296322 | LUAD | Male-baised eQTL |
| rs12683690 | chr9:2498874:C:A | - | 0.0395157343266829 | 0.0445027226296322 | LUAD | Male-baised eQTL |
| rs10974386 | chr9:4195707:G:A | - | 0.0528864016126497 | 0.0493842920070287 | LUAD | Male-baised eQTL |
| rs7868953 | chr9:4201934:G:C | - | 0.0528832013878319 | 0.0494146674183926 | LUAD | Male-baised eQTL |
| rs73373998 | chr9:1265321:T:C | - | 0.167200367157058 | 3.35279075209731e-06 | COAD | Male-baised eQTL |
| rs73374001 | chr9:1265510:C:T | - | 0.165226198759796 | 7.6833753436031e-06 | COAD | Male-baised eQTL |
| rs7852365 | chr9:6068910:C:T | - | 0.0673740564689737 | 0.0136837841474169 | COAD | Male-baised eQTL |
| rs34133170 | chr9:6076871:C:T | - | 0.0678355345041071 | 0.0167659315263974 | COAD | Male-baised eQTL |
| rs58375182 | chr9:12606852:C:T | - | 0.111942330958716 | 0.0178301715279515 | COAD | Male-baised eQTL |
| rs72700585 | chr9:14443257:C:T | - | 0.0710706767213858 | 0.0280680073654646 | COAD | Male-baised eQTL |
| rs10975420 | chr9:6062676:C:G | - | 0.0552594562872706 | 0.0290588532500634 | COAD | Male-baised eQTL |
| rs820516 | chr9:6684753:G:C | - | 0.0478197626406535 | 0.030612894747673 | COAD | Male-baised eQTL |
| rs10758743 | chr9:6066175:T:C | - | 0.0540198660425037 | 0.0367913705782205 | COAD | Male-baised eQTL |
| rs2225874 | chr9:1237423:G:A | - | -0.0674081033557158 | 0.0382877355790442 | COAD | Male-baised eQTL |
| rs10756061 | chr9:10561180:T:C | - | -0.0581937786818701 | 0.0397226671551051 | COAD | Male-baised eQTL |
| rs10756351 | chr9:1231884:G:A | - | -0.066332553819309 | 0.0450530920561527 | COAD | Male-baised eQTL |
| rs7848240 | chr9:6060647:C:T | - | 0.0516120345161528 | 0.0460227036924713 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PPAPDC2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
